Magnetic-assisted robotic surgery is a novel approach that allows internal tissue retraction using externally controlled magnetic forces, potentially reducing the need for additional surgical incisions. While prior work has demonstrated the technical feasibility of combining magnetic assistance with single-port robotic surgery, clinical outcomes data are limited. In this study, we evaluated early clinical outcomes in patients undergoing dual robotic surgery using the Da Vinci SP and the Levita MARS during single-port radical prostatectomy. We performed a retrospective review of consecutive patients and assessed perioperative metrics, pathologic outcomes, and early functional recovery. Six patients underwent dual robotic surgery without conversion to multiport or open approaches and without device-related intraoperative complications. Operative time and blood loss were consistent with reported single-port prostatectomy series. One postoperative hematoma occurred, and no high-grade complications were observed. Pathologic outcomes were acceptable, with a single positive surgical margin. Early urinary continence recovery was favorable, with most patients achieving social continence in the early postoperative period and continued improvement over time. These findings suggest that integration of magnetic-assisted robotic surgery into single-port robotic prostatectomy can be achieved safely without compromising early clinical or functional outcomes. This study provides early translational evidence supporting the clinical viability of magnetic technologies as adjuncts to advanced robotic surgery.
Taylor et al. (Fri,) studied this question.